FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs.When completed, the site will be the largest end-to-end cell culture CDMO facility in North America, housing state-of-the-art biopharmaceutical manufacturing equipment and technology, including two large manufacturing suites for large-scale monoclonal antibody drug substance and drug product manufacturing.Â
In Sep. 2022, the North Carolina Biotechnology Center (NCBiotech) and a statewide coalition of partners received a $25 million Phase 2 award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge.
A new industrial consortium led by the North Carolina Biotechnology Center will develop apprenticeships in the life sciences to strengthen workforce preparedness.